{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T07:52:39Z","timestamp":1719733959356},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00192-012-2035-1","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T19:37:32Z","timestamp":1358969852000},"page":"1073-1081","source":"Crossref","is-referenced-by-count":8,"title":["Botulinum toxin for conditions of the female pelvis"],"prefix":"10.1007","volume":"24","author":[{"given":"Dominique","family":"El-Khawand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Wehbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristene","family":"Whitmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"issue":"2","key":"2035_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000317517","volume":"85","author":"VS Hanchanale","year":"2010","unstructured":"Hanchanale VS, Rao AR, Martin FL, Matanhelia SS (2010) The unusual history and the urological applications of botulinum neurotoxin. Urol Int 85(2):125\u2013130","journal-title":"Urol Int"},{"issue":"3","key":"2035_CR2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000288223","volume":"84","author":"RK Leong","year":"2010","unstructured":"Leong RK, De Wachter SG, van Kerrebroeck PE (2010) Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review. Urol Int 84(3):245\u2013253","journal-title":"Urol Int"},{"issue":"5","key":"2035_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/NRL.0b013e31816f2cdd","volume":"14","author":"A Brashear","year":"2008","unstructured":"Brashear A (2008) Clinical comparisons of botulinum neurotoxin formulations. Neurologist 14(5):289\u2013298","journal-title":"Neurologist"},{"issue":"23","key":"2035_CR4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1080\/09638280701568296","volume":"29","author":"D Dressler","year":"2007","unstructured":"Dressler D, Benecke R (2007) Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 29(23):1761\u20131768","journal-title":"Disabil Rehabil"},{"issue":"4","key":"2035_CR5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","volume":"60","author":"F Cruz","year":"2011","unstructured":"Cruz F, Herschorn S, Aliotta P et al (2011) Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 60(4):742\u2013750","journal-title":"Eur Urol"},{"issue":"12","key":"2035_CR6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/sc.2012.76","volume":"50","author":"J Krhut","year":"2012","unstructured":"Krhut J, Samal V, Nemec D, Zvara P (2012) Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study. Spinal Cord 50(12):904\u2013907","journal-title":"Spinal Cord"},{"issue":"6","key":"2035_CR7","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.juro.2010.08.028","volume":"184","author":"TA Abdel-Meguid","year":"2010","unstructured":"Abdel-Meguid TA (2010) Botulinum toxin-A injections into neurogenic overactive bladder\u2013to include or exclude the trigone? A prospective, randomized, controlled trial. J Urol 184(6):2423\u20132428","journal-title":"J Urol"},{"key":"2035_CR8","doi-asserted-by":"crossref","unstructured":"Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D (2011) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev (12):CD005493","DOI":"10.1002\/14651858.CD005493.pub3"},{"issue":"6","key":"2035_CR9","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","volume":"184","author":"R Dmochowski","year":"2010","unstructured":"Dmochowski R, Chapple C, Nitti VW et al (2010) Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol 184(6):2416\u20132422","journal-title":"J Urol"},{"issue":"4","key":"2035_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/nau.21021","volume":"30","author":"E Rovner","year":"2011","unstructured":"Rovner E, Kennelly M, Schulte-Baukloh H, Zhou J, Haag-Molkenteller C, Dasgupta P (2011) Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn 30(4):556\u2013562","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"2035_CR11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2011.12.011","volume":"61","author":"C Dowson","year":"2012","unstructured":"Dowson C, Watkins J, Khan MS, Dasgupta P, Sahai A (2012) Repeated botulinum toxin type A Injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates. Eur Urol 61(4):834\u2013839","journal-title":"Eur Urol"},{"issue":"3","key":"2035_CR12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.eururo.2011.12.056","volume":"62","author":"DG Tincello","year":"2012","unstructured":"Tincello DG, Kenyon S, Abrams KR, Mayne C, Toozs-Hobson P, Taylor D et al (2012) Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study). Eur Urol 62(3):507\u2013514","journal-title":"Eur Urol"},{"issue":"7","key":"2035_CR13","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/nau.21054","volume":"30","author":"HC Kuo","year":"2011","unstructured":"Kuo HC (2011) Bladder base\/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics. Neurourol Urodyn 30(7):1242\u20131248","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"2035_CR14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.eururo.2011.10.043","volume":"61","author":"RP Manecksha","year":"2012","unstructured":"Manecksha RP, Cullen IM, Ahmad S et al (2012) Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity. Eur Urol 61(5):928\u2013935","journal-title":"Eur Urol"},{"issue":"4 Pt 1","key":"2035_CR15","first-page":"1359","volume":"178","author":"HC Kuo","year":"2007","unstructured":"Kuo HC (2007) Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 178(4 Pt 1):1359\u20131363","journal-title":"J Urol"},{"issue":"10","key":"2035_CR16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00192-010-1162-9","volume":"21","author":"S Tirumuru","year":"2010","unstructured":"Tirumuru S, Al-Kurdi D, Latthe P (2010) Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome\/interstitial cystitis: a systematic review. Int Urogynecol J 21(10):1285\u20131300","journal-title":"Int Urogynecol J"},{"issue":"5","key":"2035_CR17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","volume":"104","author":"HC Kuo","year":"2009","unstructured":"Kuo HC, Chancellor MB (2009) Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome. BJU Int 104(5):657\u2013661","journal-title":"BJU Int"},{"issue":"4","key":"2035_CR18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2011.07.001","volume":"60","author":"A Mangera","year":"2011","unstructured":"Mangera A, Andersson KE, Apostolidis A et al (2011) Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol 60(4):784\u2013795","journal-title":"Eur Urol"},{"issue":"12","key":"2035_CR19","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","volume":"76","author":"P Gallien","year":"2005","unstructured":"Gallien P, Reymann JM, Amarenco G, Nicolas B, de Seze M, Bellissant E (2005) Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 76(12):1670\u20131676","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2035_CR20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1479-828X.2009.01028.x","volume":"49","author":"A Rao","year":"2009","unstructured":"Rao A, Abbott J (2009) Using botulinum toxin for pelvic indications in women. Aust N Z J Obstet Gynaecol 49(4):352\u2013357","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"2035_CR21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.AOG.0000237100.29870.cc","volume":"108","author":"JA Abbott","year":"2006","unstructured":"Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG (2006) Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol 108(4):915\u2013923","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2035_CR22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1743-6109.2011.02270.x","volume":"8","author":"AT Goldstein","year":"2011","unstructured":"Goldstein AT, Burrows LJ, Kellogg-Spadt S (2011) Intralevator injection of botulinum toxin for the treatment of hypertonic pelvic floor muscle dysfunction and vestibulodynia. J Sex Med 8(5):1287\u20131290","journal-title":"J Sex Med"},{"issue":"5","key":"2035_CR23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/AOG.0b013e3181bb0dbb","volume":"114","author":"L Bertolasi","year":"2009","unstructured":"Bertolasi L, Frasson E, Cappelletti JY, Vicentini S, Bordignon M, Graziottin A (2009) Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome. Obstet Gynecol 114(5):1008\u20131016","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2035_CR24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.lgt.0000225898.37090.04","volume":"11","author":"HK Haefner","year":"2007","unstructured":"Haefner HK (2007) Report of the International Society for the Study of Vulvovaginal Disease terminology and classification of vulvodynia. J Low Genit Tract Dis 11(1):48\u201349","journal-title":"J Low Genit Tract Dis"},{"issue":"5","key":"2035_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/OGX.0b013e3182277fb7","volume":"66","author":"JC Andrews","year":"2011","unstructured":"Andrews JC (2011) Vulvodynia interventions\u2014systematic review and evidence grading. Obstet Gynecol Surv 66(5):299\u2013315","journal-title":"Obstet Gynecol Surv"},{"issue":"9","key":"2035_CR26","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1743-6109.2009.01378.x","volume":"6","author":"CD Petersen","year":"2009","unstructured":"Petersen CD, Giraldi A, Lundvall L, Kristensen E (2009) Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med 6(9):2523\u20132537","journal-title":"J Sex Med"},{"issue":"1","key":"2035_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-011-1286-5","volume":"27","author":"E Yiannakopoulou","year":"2012","unstructured":"Yiannakopoulou E (2012) Botulinum toxin and anal fissure: efficacy and safety systematic review. Int J Colorectal Dis 27(1):1\u20139","journal-title":"Int J Colorectal Dis"},{"issue":"10","key":"2035_CR28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/BF02050639","volume":"36","author":"WH Jost","year":"1993","unstructured":"Jost WH, Schimrigk K (1993) Use of botulinum toxin in anal fissure. Dis Colon Rectum 36(10):974","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"2035_CR29","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/BF02234220","volume":"42","author":"DC Nyam","year":"1999","unstructured":"Nyam DC, Pemberton JH (1999) Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence. Dis Colon Rectum 42(10):1306\u20131310","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"2035_CR30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00423-012-0948-2","volume":"397","author":"N Valizadeh","year":"2012","unstructured":"Valizadeh N, Jalaly NY, Hassanzadeh M et al (2012) Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal fissure: randomized prospective controlled trial. Langenbecks Arch Surg 397(7):1093\u20131098","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"2035_CR31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1572-0241.2005.50120.x","volume":"100","author":"F Sierra","year":"2005","unstructured":"Sierra F (2005) Evidence-Based Medicine (EBM) in practice: applying number needed to treat and number needed to harm. Am J Gastroenterol 100(8):1661\u20131663","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2035_CR32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10350-004-6528-y","volume":"46","author":"BB Mentes","year":"2003","unstructured":"Mentes BB, Irkorucu O, Akin M, Leventoglu S, Tatlicioglu E (2003) Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure. Dis Colon Rectum 46(2):232\u2013237","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"2035_CR33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9610(99)00255-X","volume":"179","author":"G Maria","year":"2000","unstructured":"Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (2000) Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg 179(1):46\u201350","journal-title":"Am J Surg"},{"issue":"2","key":"2035_CR34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/bjs.5514","volume":"94","author":"G Brisinda","year":"2007","unstructured":"Brisinda G, Cadeddu F, Brandara F, Marniga G, Maria G (2007) Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure. Br J Surg 94(2):162\u2013167","journal-title":"Br J Surg"},{"issue":"6","key":"2035_CR35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2004.01895.x","volume":"19","author":"G Brisinda","year":"2004","unstructured":"Brisinda G, Albanese A, Cadeddu F et al (2004) Botulinum neurotoxin to treat chronic anal fissure: results of a randomized \u201cBotox vs. Dysport\u201d controlled trial. Aliment Pharmacol Ther 19(6):695\u2013701","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2035_CR36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF01318172","volume":"30","author":"DM Preston","year":"1985","unstructured":"Preston DM, Lennard-Jones JE (1985) Anismus in chronic constipation. Dig Dis Sci 30(5):413\u2013418","journal-title":"Dig Dis Sci"},{"issue":"2","key":"2035_CR37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1463-1318.2011.02561.x","volume":"14","author":"R Hompes","year":"2012","unstructured":"Hompes R, Harmston C, Wijffels N, Jones OM, Cunningham C, Lindsey I (2012) Excellent response rate of anismus to botulinum toxin if rectal prolapse misdiagnosed as anismus (\u2018pseudoanismus\u2019) is excluded. Colorectal Dis 14(2):224\u2013230","journal-title":"Colorectal Dis"},{"issue":"8","key":"2035_CR38","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s11605-010-1229-4","volume":"14","author":"M Faried","year":"2010","unstructured":"Faried M, El Nakeeb A, Youssef M, Omar W, El Monem HA (2010) Comparative study between surgical and non-surgical treatment of anismus in patients with symptoms of obstructed defecation: a prospective randomized study. J Gastrointest Surg 14(8):1235\u20131243","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"2035_CR39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.mcg.0000135929.78074.8c","volume":"38","author":"SS Rao","year":"2004","unstructured":"Rao SS, Tuteja AK, Vellema T, Kempf J, Stessman M (2004) Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol 38(8):680\u2013685","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"2035_CR40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0016-5085(93)90896-K","volume":"105","author":"NJ Talley","year":"1993","unstructured":"Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd (1993) Functional constipation and outlet delay: a population-based study. Gastroenterology 105(3):781\u2013790","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"2035_CR41","first-page":"S34","volume":"4","author":"JA DiPalma","year":"2004","unstructured":"DiPalma JA (2004) Current treatment options for chronic constipation. Rev Gastroenterol Disord 4 [Suppl 2]:S34\u2013S42","journal-title":"Rev Gastroenterol Disord"},{"issue":"7","key":"2035_CR42","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF02054442","volume":"39","author":"UC Park","year":"1996","unstructured":"Park UC, Choi SK, Piccirillo MF, Verzaro R, Wexner SD (1996) Patterns of anismus and the relation to biofeedback therapy. Dis Colon Rectum 39(7):768\u2013773","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"2035_CR43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00384-008-0567-0","volume":"24","author":"M Farid","year":"2009","unstructured":"Farid M, El Monem HA, Omar W et al (2009) Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients. Int J Colorectal Dis 24(1):115\u2013120","journal-title":"Int J Colorectal Dis"},{"issue":"10","key":"2035_CR44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/BF02081409","volume":"39","author":"JS Joo","year":"1996","unstructured":"Joo JS, Agachan F, Wolff B, Nogueras JJ, Wexner SD (1996) Initial North American experience with botulinum toxin type A for treatment of anismus. Dis Colon Rectum 39(10):1107\u20131111","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"2035_CR45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000018630","volume":"15","author":"A Shafik","year":"1998","unstructured":"Shafik A, El-Sibai O (1998) Botulin toxin in the treatment of nonrelaxing puborectalis syndrome. Dig Surg 15(4):347\u2013351","journal-title":"Dig Surg"},{"issue":"3","key":"2035_CR46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF02258305","volume":"43","author":"G Maria","year":"2000","unstructured":"Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Albanese A (2000) Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. Dis Colon Rectum 43(3):376\u2013380","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"2035_CR47","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/BF02234461","volume":"44","author":"Y Ron","year":"2001","unstructured":"Ron Y, Avni Y, Lukovetski A et al (2001) Botulinum toxin type-A in therapy of patients with anismus. Dis Colon Rectum 44(12):1821\u20131826","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"2035_CR48","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1111\/j.1572-0241.2006.00791.x","volume":"101","author":"G Maria","year":"2006","unstructured":"Maria G, Cadeddu F, Brandara F, Marniga G, Brisinda G (2006) Experience with type A botulinum toxin for treatment of outlet-type constipation. Am J Gastroenterol 101(11):2570\u20132575","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"2035_CR49","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1111\/j.1463-1318.2011.02684.x","volume":"13","author":"JR Hollingshead","year":"2011","unstructured":"Hollingshead JR, Maeda Y, Brown TJ, Warusavitarne J, Vaizey CJ (2011) Long-term outcome of the use of botulinum toxin injection for functional anal pain. Colorectal Dis 13(9):e293\u2013e296","journal-title":"Colorectal Dis"},{"issue":"5","key":"2035_CR50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF02234562","volume":"44","author":"J Christiansen","year":"2001","unstructured":"Christiansen J, Bruun E, Skjoldbye B, Hagen K (2001) Chronic idiopathic anal pain: analysis of ultrasonography, pathology, and treatment. Dis Colon Rectum 44(5):661\u2013665","journal-title":"Dis Colon Rectum"},{"issue":"8613","key":"2035_CR51","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(88)90188-2","volume":"2","author":"RI Hallan","year":"1988","unstructured":"Hallan RI, Williams NS, Melling J, Waldron DJ, Womack NR, Morrison JF (1988) Treatment of anismus in intractable constipation with botulinum A toxin. Lancet 2(8613):714\u2013717","journal-title":"Lancet"},{"issue":"4","key":"2035_CR52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/SPV.0b013e318224e0d7","volume":"17","author":"JP Shepherd","year":"2011","unstructured":"Shepherd JP, Lowder JL, Leng WW, Smith KJ (2011) InterStim sacral neuromodulation and botox botulinum-a toxin intradetrusor injections for refractory urge urinary incontinence: a decision analysis comparing outcomes including efficacy and complications. Female Pelvic Med Reconstr Surg 17(4):199\u2013203","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"6","key":"2035_CR53","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.juro.2009.08.031","volume":"182","author":"NY Siddiqui","year":"2009","unstructured":"Siddiqui NY, Amundsen CL, Visco AG, Myers ER, Wu JM (2009) Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol 182(6):2799\u20132804","journal-title":"J Urol"},{"issue":"4","key":"2035_CR54","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1464-410X.2010.09905.x","volume":"108","author":"RK Leong","year":"2011","unstructured":"Leong RK, de Wachter SG, Joore MA, van Kerrebroeck PE (2011) Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder. BJU Int 108(4):558\u2013564","journal-title":"BJU Int"},{"issue":"6","key":"2035_CR55","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","volume":"185","author":"PM Hanno","year":"2011","unstructured":"Hanno PM, Burks DA, Clemens JQ et al (2011) AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol 185(6):2162\u20132170","journal-title":"J Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-012-2035-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-012-2035-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-012-2035-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T04:17:16Z","timestamp":1714882636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-012-2035-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2035"],"URL":"https:\/\/doi.org\/10.1007\/s00192-012-2035-1","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}